In a recent article, Abdelgadir et al. [1] reported about two
pediatric patients with non-mosaic trisomy 22 of whom the 5 yearold
female presented with left ventricular hypertrabeculation,
also known as noncompaction (LVHT) [1]. We have the following
comments and concerns.
Generally, LVHT is regarded as a congenital abnormality of
the left ventricular myocardium characterised by a two-layered
structure of the myocardium, consisting of a thin compacted
outer (pericardial) and a non-compacted inner (endocardial)
layer [2]. The non-compacted layer is characterised by a complex
interwoven meshwork of trabeculations, which are separated
by deep intertrabecular recesses reaching the compacted layer.
LVHT is most frequently located in the apex, and the lateral wall
but usually spares the septum [2]. LVHT may be associated with
other cardiac abnormalities (non-isolated) or may occur as the
sole morphological abnormality (isolated LVHT) [3]. Isolated and
non-isolated LVHT are frequently associated with ventricular
arrhythmias or systolic dysfunction [3]. There are also indications
that the frequency of stroke or embolism is increased in LVHT due to
thrombus formation within the intertrabecular spaces [2,3]. In the
vast majority of the cases LVHT is assumed to be present already at
birth but no systematic studies on the prevalence of LVHT in early
infancy have been carried out so far. In the abstract Abdelgadir et al.
claim that their report is the first one about a patient with trisomy
22 and LVHT. However, LVHT has been previously described in
trisomy 22 [4]. In an unborn girl with trisomy 22 Wang et al.
described in 2007 LVHT on fetal echocardiography [4]. Contrary to
the report by Wang et al., LVHT in Abdelgadir’s case was absent on
fetal echocardiography [1]. Fetal echocardiography showed only
moderate tricuspid regurgitation and a small pericardial effusion
[1].
No other echocardiography’s were carried out during gestation.
Postnatal transthoracic echocardiography surprisingly revealed
LVHT associated with a large atrial septal defect, persistent ductus
arteriosus, and moderate tricuspid regurgitation. Comparison
between fetal and neonatal echocardiography’s suggests that
LVHT in the presented patient was acquired. Acquired LVHT has
been only rarely described and is associated with neuromuscular
disorders (NMDs) [5]. To exclude that LVHT was missed on fetal
intrauterine echocardiography or hidden during gestation and
unmasked during delivery or shortly afterwards, the intrauterine
examination should be reviewed. If LVHT is truly absent on this
initial examination, the authors should provide an explanation
why LVHT developed between the intrauterine echocardiography
and the neonatal examination. Isolated LVHT with normal systolic
function was still present at age 1y. In addition to chromosomal
abnormalities LVHT is frequently associated with NMDs [5]. Was
there any indication for a second trouble such as an NMD in the
presented patient? Was the family history positive for NMD? Which
were the CK levels and was an electromyogram recorded? Overall,
it should be emphasised that the presented patient had acquired
LVHT, that it is not the first report of a patient with trisomy 22 and
LVHT, that investigations for NMD should be initiated, and that the
patient requires close follow-up to prevent systolic dysfunction or
severe arrhythmias.